| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Early Detection of Cancer | 8 | 2022 | 422 | 2.350 |
Why?
|
| Colorectal Neoplasms | 8 | 2022 | 980 | 2.230 |
Why?
|
| Aortic Aneurysm, Thoracic | 9 | 2021 | 89 | 2.000 |
Why?
|
| Emigrants and Immigrants | 6 | 2018 | 43 | 1.740 |
Why?
|
| Blood Vessel Prosthesis Implantation | 9 | 2021 | 227 | 1.660 |
Why?
|
| Transcatheter Aortic Valve Replacement | 7 | 2021 | 56 | 1.590 |
Why?
|
| Endovascular Procedures | 10 | 2021 | 290 | 1.440 |
Why?
|
| Aortic Valve | 8 | 2021 | 246 | 1.240 |
Why?
|
| Aortic Aneurysm | 5 | 2020 | 80 | 1.190 |
Why?
|
| Patient Navigation | 3 | 2018 | 14 | 1.170 |
Why?
|
| Colonoscopy | 3 | 2022 | 281 | 1.020 |
Why?
|
| Aortic Valve Stenosis | 3 | 2021 | 146 | 0.990 |
Why?
|
| Heart Valve Prosthesis Implantation | 4 | 2020 | 179 | 0.970 |
Why?
|
| Heart Valve Prosthesis | 5 | 2021 | 98 | 0.710 |
Why?
|
| Hepatitis B, Chronic | 2 | 2018 | 32 | 0.690 |
Why?
|
| Computed Tomography Angiography | 4 | 2022 | 155 | 0.660 |
Why?
|
| Aortography | 2 | 2018 | 65 | 0.640 |
Why?
|
| Communication Barriers | 1 | 2018 | 30 | 0.600 |
Why?
|
| Chicago | 7 | 2020 | 1434 | 0.590 |
Why?
|
| Intention | 1 | 2018 | 51 | 0.590 |
Why?
|
| Health Education | 1 | 2018 | 105 | 0.570 |
Why?
|
| Middle Aged | 30 | 2021 | 26148 | 0.560 |
Why?
|
| Software | 1 | 2021 | 669 | 0.540 |
Why?
|
| Public Health Surveillance | 1 | 2016 | 22 | 0.540 |
Why?
|
| Bioprosthesis | 3 | 2021 | 39 | 0.530 |
Why?
|
| Aged | 22 | 2021 | 19254 | 0.510 |
Why?
|
| Humans | 53 | 2022 | 89970 | 0.510 |
Why?
|
| Education, Public Health Professional | 1 | 2015 | 2 | 0.510 |
Why?
|
| Women's Health | 1 | 2016 | 103 | 0.500 |
Why?
|
| Community-Based Participatory Research | 1 | 2015 | 37 | 0.490 |
Why?
|
| Urban Health | 1 | 2015 | 56 | 0.490 |
Why?
|
| Gastrointestinal Diseases | 1 | 2016 | 151 | 0.480 |
Why?
|
| Colonic Polyps | 1 | 2015 | 132 | 0.460 |
Why?
|
| Female | 35 | 2022 | 46595 | 0.450 |
Why?
|
| Mass Screening | 4 | 2020 | 647 | 0.450 |
Why?
|
| Male | 35 | 2022 | 42682 | 0.430 |
Why?
|
| Health Status Disparities | 1 | 2015 | 191 | 0.420 |
Why?
|
| Retrospective Studies | 19 | 2022 | 9210 | 0.410 |
Why?
|
| Primary Health Care | 1 | 2016 | 352 | 0.410 |
Why?
|
| Michigan | 7 | 2021 | 54 | 0.410 |
Why?
|
| Treatment Outcome | 16 | 2022 | 8273 | 0.400 |
Why?
|
| Education, Medical | 1 | 2015 | 243 | 0.400 |
Why?
|
| Aorta | 3 | 2021 | 289 | 0.360 |
Why?
|
| Stents | 4 | 2021 | 412 | 0.350 |
Why?
|
| Endocarditis, Bacterial | 2 | 2020 | 39 | 0.350 |
Why?
|
| Hospital Mortality | 7 | 2020 | 408 | 0.340 |
Why?
|
| Minority Groups | 3 | 2020 | 147 | 0.340 |
Why?
|
| Blood Vessel Prosthesis | 3 | 2021 | 244 | 0.340 |
Why?
|
| Pain, Postoperative | 3 | 2021 | 256 | 0.340 |
Why?
|
| Acute Disease | 6 | 2022 | 846 | 0.310 |
Why?
|
| Time Factors | 9 | 2021 | 5359 | 0.310 |
Why?
|
| Mesenteric Ischemia | 2 | 2018 | 7 | 0.300 |
Why?
|
| Religion and Psychology | 1 | 2006 | 18 | 0.280 |
Why?
|
| Community-Institutional Relations | 1 | 2006 | 29 | 0.270 |
Why?
|
| Analgesics, Opioid | 2 | 2021 | 451 | 0.270 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2021 | 481 | 0.260 |
Why?
|
| Follow-Up Studies | 5 | 2020 | 3680 | 0.260 |
Why?
|
| Behavior Therapy | 1 | 2006 | 88 | 0.260 |
Why?
|
| Spirituality | 1 | 2006 | 87 | 0.260 |
Why?
|
| Rural Population | 1 | 2006 | 147 | 0.260 |
Why?
|
| China | 3 | 2020 | 235 | 0.260 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2006 | 39 | 0.260 |
Why?
|
| Ischemia | 2 | 2018 | 253 | 0.250 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2006 | 47 | 0.250 |
Why?
|
| Religion and Medicine | 1 | 2006 | 122 | 0.250 |
Why?
|
| Weight Loss | 1 | 2006 | 233 | 0.240 |
Why?
|
| United States | 9 | 2020 | 7108 | 0.240 |
Why?
|
| Insurance Coverage | 2 | 2015 | 127 | 0.230 |
Why?
|
| Healthcare Disparities | 4 | 2016 | 432 | 0.230 |
Why?
|
| Aorta, Thoracic | 2 | 2021 | 168 | 0.220 |
Why?
|
| Adult | 10 | 2020 | 26822 | 0.210 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2015 | 539 | 0.210 |
Why?
|
| Evidence-Based Medicine | 3 | 2020 | 435 | 0.210 |
Why?
|
| Curriculum | 3 | 2015 | 573 | 0.210 |
Why?
|
| Risk Factors | 8 | 2021 | 5559 | 0.200 |
Why?
|
| Risk Assessment | 5 | 2018 | 2328 | 0.200 |
Why?
|
| Genetic Testing | 1 | 2006 | 543 | 0.190 |
Why?
|
| Text Messaging | 1 | 2022 | 31 | 0.190 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 1 | 2021 | 29 | 0.190 |
Why?
|
| Diverticulum | 1 | 2021 | 45 | 0.190 |
Why?
|
| Long Term Adverse Effects | 1 | 2020 | 6 | 0.180 |
Why?
|
| Hepatitis B Surface Antigens | 2 | 2018 | 23 | 0.180 |
Why?
|
| Risk | 2 | 2020 | 657 | 0.170 |
Why?
|
| Intercostal Nerves | 1 | 2020 | 3 | 0.170 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2021 | 194 | 0.170 |
Why?
|
| Endocarditis | 1 | 2020 | 22 | 0.170 |
Why?
|
| Deglutition Disorders | 1 | 2021 | 119 | 0.170 |
Why?
|
| Denervation | 1 | 2020 | 25 | 0.170 |
Why?
|
| Obesity | 1 | 2006 | 972 | 0.170 |
Why?
|
| Aged, 80 and over | 6 | 2021 | 6783 | 0.170 |
Why?
|
| Neoplasms | 1 | 2015 | 3065 | 0.170 |
Why?
|
| Vulnerable Populations | 1 | 2020 | 84 | 0.170 |
Why?
|
| Abscess | 1 | 2020 | 94 | 0.170 |
Why?
|
| Cerebrovascular Disorders | 1 | 2020 | 145 | 0.170 |
Why?
|
| Prosthesis-Related Infections | 1 | 2020 | 61 | 0.170 |
Why?
|
| Marketing of Health Services | 1 | 2019 | 15 | 0.170 |
Why?
|
| Patient Admission | 1 | 2020 | 114 | 0.170 |
Why?
|
| Panax | 2 | 2011 | 170 | 0.170 |
Why?
|
| Cryosurgery | 1 | 2020 | 55 | 0.170 |
Why?
|
| Narcotics | 1 | 2020 | 71 | 0.160 |
Why?
|
| Prosthesis Failure | 1 | 2020 | 117 | 0.160 |
Why?
|
| Disease Outbreaks | 1 | 2020 | 156 | 0.160 |
Why?
|
| Hospitals, High-Volume | 1 | 2019 | 38 | 0.160 |
Why?
|
| Splanchnic Circulation | 1 | 2018 | 14 | 0.160 |
Why?
|
| Postoperative Complications | 5 | 2021 | 2314 | 0.160 |
Why?
|
| Cerebrovascular Circulation | 1 | 2020 | 232 | 0.160 |
Why?
|
| Informed Consent | 1 | 2021 | 275 | 0.160 |
Why?
|
| Heart Defects, Congenital | 1 | 2021 | 365 | 0.160 |
Why?
|
| Chronic Disease | 2 | 2020 | 958 | 0.150 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2020 | 120 | 0.150 |
Why?
|
| Pain Management | 1 | 2020 | 144 | 0.150 |
Why?
|
| Occult Blood | 1 | 2018 | 18 | 0.150 |
Why?
|
| Aortic Rupture | 1 | 2018 | 57 | 0.150 |
Why?
|
| Device Removal | 1 | 2020 | 168 | 0.150 |
Why?
|
| Endothelial Cells | 1 | 2021 | 464 | 0.150 |
Why?
|
| Hospitals, University | 1 | 2018 | 196 | 0.150 |
Why?
|
| Vascular Calcification | 1 | 2018 | 51 | 0.140 |
Why?
|
| Forecasting | 1 | 2018 | 304 | 0.140 |
Why?
|
| Health Expenditures | 1 | 2018 | 90 | 0.140 |
Why?
|
| Quantitative Trait Loci | 1 | 2021 | 615 | 0.140 |
Why?
|
| Community Health Services | 1 | 2018 | 82 | 0.140 |
Why?
|
| Viscera | 1 | 2016 | 18 | 0.140 |
Why?
|
| Reoperation | 4 | 2020 | 604 | 0.140 |
Why?
|
| Registries | 1 | 2021 | 808 | 0.140 |
Why?
|
| Influenza, Human | 1 | 2020 | 340 | 0.140 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 841 | 0.140 |
Why?
|
| Hospitals | 1 | 2019 | 303 | 0.140 |
Why?
|
| Seroepidemiologic Studies | 1 | 2016 | 54 | 0.140 |
Why?
|
| Prognosis | 3 | 2020 | 3798 | 0.140 |
Why?
|
| Patient Participation | 1 | 2018 | 226 | 0.130 |
Why?
|
| Kidney Failure, Chronic | 1 | 2020 | 414 | 0.130 |
Why?
|
| Directive Counseling | 1 | 2016 | 35 | 0.130 |
Why?
|
| Cost-Benefit Analysis | 1 | 2018 | 467 | 0.130 |
Why?
|
| Risk Reduction Behavior | 1 | 2016 | 97 | 0.130 |
Why?
|
| Vietnam | 1 | 2015 | 14 | 0.120 |
Why?
|
| Cambodia | 1 | 2015 | 6 | 0.120 |
Why?
|
| Polyps | 1 | 2015 | 29 | 0.120 |
Why?
|
| Thrombosis | 1 | 2018 | 302 | 0.120 |
Why?
|
| Referral and Consultation | 1 | 2018 | 345 | 0.120 |
Why?
|
| Cultural Diversity | 2 | 2013 | 57 | 0.120 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2015 | 67 | 0.120 |
Why?
|
| Schools, Medical | 2 | 2013 | 136 | 0.120 |
Why?
|
| Communication | 1 | 2018 | 461 | 0.120 |
Why?
|
| Universities | 1 | 2015 | 146 | 0.120 |
Why?
|
| Acute Kidney Injury | 1 | 2018 | 317 | 0.120 |
Why?
|
| Logistic Models | 1 | 2018 | 1214 | 0.120 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 1055 | 0.110 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 1732 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2021 | 1180 | 0.100 |
Why?
|
| Sexual and Gender Minorities | 1 | 2016 | 213 | 0.100 |
Why?
|
| Personnel Selection | 1 | 2013 | 60 | 0.100 |
Why?
|
| Socioeconomic Factors | 1 | 2015 | 596 | 0.100 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 2767 | 0.100 |
Why?
|
| Age Factors | 1 | 2016 | 1880 | 0.090 |
Why?
|
| Dietary Fats | 1 | 2011 | 135 | 0.090 |
Why?
|
| Faculty, Medical | 1 | 2013 | 188 | 0.090 |
Why?
|
| Decision Making | 1 | 2016 | 670 | 0.090 |
Why?
|
| School Admission Criteria | 1 | 2010 | 28 | 0.090 |
Why?
|
| Down-Regulation | 1 | 2011 | 520 | 0.090 |
Why?
|
| Ginsenosides | 1 | 2011 | 123 | 0.090 |
Why?
|
| Plant Extracts | 1 | 2011 | 245 | 0.080 |
Why?
|
| Sex Factors | 1 | 2012 | 1075 | 0.080 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2011 | 449 | 0.080 |
Why?
|
| Pain Measurement | 2 | 2020 | 332 | 0.080 |
Why?
|
| Physicians | 1 | 2016 | 692 | 0.080 |
Why?
|
| ErbB Receptors | 1 | 2011 | 499 | 0.080 |
Why?
|
| Regional Blood Flow | 2 | 2018 | 198 | 0.070 |
Why?
|
| Colonic Neoplasms | 1 | 2011 | 571 | 0.070 |
Why?
|
| Diet, Reducing | 1 | 2006 | 29 | 0.070 |
Why?
|
| North Carolina | 1 | 2006 | 51 | 0.070 |
Why?
|
| Prospective Studies | 1 | 2015 | 4331 | 0.070 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2021 | 608 | 0.060 |
Why?
|
| Focus Groups | 1 | 2006 | 177 | 0.060 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2008 | 182 | 0.060 |
Why?
|
| Sex Distribution | 1 | 2006 | 171 | 0.060 |
Why?
|
| Family Health | 1 | 2006 | 162 | 0.060 |
Why?
|
| Survival Rate | 2 | 2020 | 1899 | 0.060 |
Why?
|
| Leadership | 1 | 2006 | 141 | 0.060 |
Why?
|
| Students, Medical | 1 | 2010 | 425 | 0.060 |
Why?
|
| Internal Medicine | 1 | 2008 | 362 | 0.060 |
Why?
|
| Young Adult | 1 | 2016 | 6410 | 0.060 |
Why?
|
| Adolescent | 1 | 2016 | 9342 | 0.050 |
Why?
|
| Exercise | 1 | 2006 | 328 | 0.050 |
Why?
|
| Body Mass Index | 1 | 2006 | 776 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2020 | 2887 | 0.050 |
Why?
|
| Cathartics | 1 | 2022 | 27 | 0.050 |
Why?
|
| Subclavian Artery | 1 | 2021 | 43 | 0.050 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2021 | 46 | 0.050 |
Why?
|
| Caspase 3 | 1 | 2021 | 162 | 0.050 |
Why?
|
| Aftercare | 1 | 2021 | 88 | 0.040 |
Why?
|
| Medical Overuse | 1 | 2020 | 36 | 0.040 |
Why?
|
| Introns | 1 | 2021 | 301 | 0.040 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2021 | 241 | 0.040 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2020 | 59 | 0.040 |
Why?
|
| Prosthesis Design | 1 | 2020 | 299 | 0.040 |
Why?
|
| Surveys and Questionnaires | 2 | 2020 | 2655 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2020 | 200 | 0.040 |
Why?
|
| Vascular Grafting | 1 | 2018 | 16 | 0.040 |
Why?
|
| Episode of Care | 1 | 2018 | 7 | 0.040 |
Why?
|
| Patient Discharge | 1 | 2021 | 326 | 0.040 |
Why?
|
| Seasons | 1 | 2020 | 240 | 0.040 |
Why?
|
| Hepatitis B Vaccines | 1 | 2018 | 16 | 0.040 |
Why?
|
| Vascular Surgical Procedures | 1 | 2019 | 149 | 0.040 |
Why?
|
| Hepatitis B virus | 1 | 2018 | 45 | 0.040 |
Why?
|
| Quality Improvement | 1 | 2022 | 457 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2020 | 855 | 0.040 |
Why?
|
| Glomerular Filtration Rate | 1 | 2018 | 277 | 0.040 |
Why?
|
| Time-to-Treatment | 1 | 2018 | 124 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2006 | 2363 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2018 | 312 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2021 | 1867 | 0.030 |
Why?
|
| Kidney | 1 | 2022 | 1148 | 0.030 |
Why?
|
| Critical Pathways | 1 | 2016 | 37 | 0.030 |
Why?
|
| Stereotyping | 1 | 2016 | 15 | 0.030 |
Why?
|
| Health Communication | 1 | 2016 | 13 | 0.030 |
Why?
|
| Genome, Human | 1 | 2021 | 791 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2018 | 281 | 0.030 |
Why?
|
| Delayed Diagnosis | 1 | 2016 | 34 | 0.030 |
Why?
|
| Culture | 1 | 2016 | 53 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2018 | 1498 | 0.030 |
Why?
|
| Length of Stay | 1 | 2018 | 749 | 0.030 |
Why?
|
| Patient Selection | 1 | 2018 | 682 | 0.030 |
Why?
|
| Pandemics | 1 | 2020 | 778 | 0.030 |
Why?
|
| Insurance, Health | 1 | 2015 | 164 | 0.030 |
Why?
|
| Incidence | 1 | 2018 | 1603 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2021 | 1691 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2021 | 1983 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 358 | 0.030 |
Why?
|
| Health Services Accessibility | 1 | 2015 | 436 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2013 | 344 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2013 | 306 | 0.020 |
Why?
|
| Physician-Patient Relations | 1 | 2016 | 625 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2011 | 194 | 0.020 |
Why?
|
| Heart Failure | 1 | 2020 | 1253 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2011 | 315 | 0.020 |
Why?
|
| Mutation | 1 | 2021 | 4168 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2011 | 667 | 0.020 |
Why?
|
| Data Collection | 1 | 2010 | 377 | 0.020 |
Why?
|
| Colon | 1 | 2011 | 521 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2018 | 2677 | 0.020 |
Why?
|
| Algorithms | 1 | 2016 | 1913 | 0.020 |
Why?
|
| Bacteria | 1 | 2011 | 486 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2013 | 1730 | 0.020 |
Why?
|
| HIV Infections | 1 | 2016 | 848 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2018 | 3475 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 2011 | 806 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2011 | 2587 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2011 | 2393 | 0.010 |
Why?
|
| Mice | 1 | 2011 | 11851 | 0.010 |
Why?
|
| Animals | 1 | 2011 | 27528 | 0.010 |
Why?
|